These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11285326)

  • 1. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women.
    Goodman-Gruen D; Kritz-Silverstein D
    J Nutr; 2001 Apr; 131(4):1202-6. PubMed ID: 11285326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usual dietary isoflavone intake and body composition in postmenopausal women.
    Goodman-Gruen D; Kritz-Silverstein D
    Menopause; 2003; 10(5):427-32. PubMed ID: 14501604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY; Shaw NS; Tsai KS; Chen CY
    J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
    Ho SC; Chen YM; Ho SS; Woo JL
    Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women.
    Kritz-Silverstein D; Goodman-Gruen DL
    J Womens Health Gend Based Med; 2002; 11(1):69-78. PubMed ID: 11860727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial.
    Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
    J Womens Health (Larchmt); 2008 Oct; 17(8):1363-9. PubMed ID: 18788990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women.
    Frankenfeld CL; Patterson RE; Horner NK; Neuhouser ML; Skor HE; Kalhorn TF; Howald WN; Lampe JW
    Am J Clin Nutr; 2003 Mar; 77(3):674-80. PubMed ID: 12600860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.
    Wangen KE; Duncan AM; Xu X; Kurzer MS
    Am J Clin Nutr; 2001 Feb; 73(2):225-31. PubMed ID: 11157317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.
    Mangano KM; Hutchins-Wiese HL; Kenny AM; Walsh SJ; Abourizk RH; Bruno RS; Lipcius R; Fall P; Kleppinger A; Kenyon-Pesce L; Prestwood KM; Kerstetter JE
    Nutr Res; 2013 Dec; 33(12):1026-33. PubMed ID: 24267042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
    Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
    Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary intake of isoflavones is associated with a lower prevalence of subclinical cardiovascular disease in postmenopausal women: cross-sectional study.
    Ferreira LL; Silva TR; Maturana MA; Spritzer PM
    J Hum Nutr Diet; 2019 Dec; 32(6):810-818. PubMed ID: 31305957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.
    Potter SM; Baum JA; Teng H; Stillman RJ; Shay NF; Erdman JW
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1375S-1379S. PubMed ID: 9848502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women.
    Llaneza P; González C; Fernández-Iñarrea J; Alonso A; Díaz F; Pérez-López FR
    Climacteric; 2012 Dec; 15(6):611-20. PubMed ID: 22191384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women.
    Weickert MO; Reimann M; Otto B; Hall WL; Vafeiadou K; Hallund J; Ferrari M; Talbot D; Branca F; Bügel S; Williams CM; Zunft HJ; Koebnick C
    J Negat Results Biomed; 2006 Aug; 5():11. PubMed ID: 16907966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women.
    Liu ZM; Ho SC; Chen YM; Ho YP
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):712-9. PubMed ID: 21429720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.
    Atteritano M; Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Mazzaferro S; D'Anna R; Cannata ML; Gaudio A; Frisina A; Frisina N; Corrado F; Cancellieri F; Lubrano C; Bonaiuto M; Adamo EB; Squadrito F
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3068-75. PubMed ID: 17682090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.